Latest Accounting News

Airtasker Limited showcased strong FY25 financials and unveiled aggressive growth plans in the UK and US, supported by strategic media partnerships and core platform investments.

Finaccess Restauración, S.L. has closed its takeover offer for Restaurant Brands New Zealand Limited, securing approximately 98% ownership and initiating compulsory acquisition of remaining shares ahead of the company’s delisting from NZX and ASX.

Hancock & Gore reports a statutory loss for FY25 amid major acquisitions and strategic transformation, setting sights on $200m revenue by FY27 as it rebrands to Schoolblazer Limited.

Straker Ltd reports a solid first half of FY26 with positive EBITDA and a renewed IBM partnership, despite a 15% revenue decline amid challenging market conditions.

Straker Limited has significantly narrowed its interim loss despite a 15% revenue decline, driven by cost efficiencies and the absence of prior non-cash charges. The company also renewed a strategic $28 million partnership with IBM, reinforcing its AI language technology ambitions.

Temple & Webster Group delivered a robust FY25 with 21% revenue growth and expanded into New Zealand, reaffirming its ambitious growth and profitability targets for FY26.

Comms Group Limited reported a steady FY25 with revenue growth and a strong start to FY26, driven by the recent TasmaNet acquisition and expanding global contracts. The company is targeting over $75 million in annualised revenue and aims to boost EBITDA to $9-10 million.

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.

IVE Group Limited reported a robust FY25 with significant profit growth and margin expansion, driven by strategic logistics expansions and the rising Lasoo e-commerce platform. Despite a softer FY26 start, the company maintains steady dividends and growth ambitions.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

WEB Travel Group has reported a stellar first half of FY26, posting a 22% rise in Total Transaction Value to $3.2 billion alongside strong EBITDA growth, signaling robust momentum ahead of full-year results.